Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

A comprehensive tool for measuring mammographic density changes over time.

Eriksson M, Li J, Leifland K, Czene K, Hall P.

Breast Cancer Res Treat. 2018 Jun;169(2):371-379. doi: 10.1007/s10549-018-4690-5. Epub 2018 Feb 1.

2.

A clinical model for identifying the short-term risk of breast cancer.

Eriksson M, Czene K, Pawitan Y, Leifland K, Darabi H, Hall P.

Breast Cancer Res. 2017 Mar 14;19(1):29. doi: 10.1186/s13058-017-0820-y.

3.

[Mammography, ultrasound and needle biopsy is the base for diagnostic imaging].

Zackrisson S, Lång K, Leifland K, Hall P, Andersson I.

Lakartidningen. 2017 Feb 14;114. pii: EECU. Swedish. No abstract available.

4.

Cohort Profile: The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA).

Gabrielson M, Eriksson M, Hammarström M, Borgquist S, Leifland K, Czene K, Hall P.

Int J Epidemiol. 2017 Dec 1;46(6):1740-1741g. doi: 10.1093/ije/dyw357. No abstract available.

5.

Comparison of handheld ultrasound and automated breast ultrasound in women recalled after mammography screening.

Hellgren R, Dickman P, Leifland K, Saracco A, Hall P, Celebioglu F.

Acta Radiol. 2017 May;58(5):515-520. doi: 10.1177/0284185116665421. Epub 2016 Sep 30.

PMID:
27565633
6.
7.

A new method to gently place biopsy needles or treatment electrodes into tissues with high target precision.

Wiksell H, Löfgren L, Schässburger KU, Leifland K, Thorneman K, Auer G.

Phys Med. 2016 May;32(5):724-7. doi: 10.1016/j.ejmp.2016.04.007. Epub 2016 May 4.

PMID:
27132032
8.

Automated measurement of volumetric mammographic density: a tool for widespread breast cancer risk assessment.

Brand JS, Czene K, Shepherd JA, Leifland K, Heddson B, Sundbom A, Eriksson M, Li J, Humphreys K, Hall P.

Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1764-72. doi: 10.1158/1055-9965.EPI-13-1219. Epub 2014 Jul 10.

9.

Contrast-enhanced ultrasound using real-time contrast harmonic imaging in invasive breast cancer: comparison of enhancement dynamics with three different doses of contrast agent.

Saracco A, Szabó BK, Aspelin P, Leifland K, Tánczos E, Wilczek B, Axelsson R.

Acta Radiol. 2015 Jan;56(1):34-41. doi: 10.1177/0284185114520860. Epub 2014 Jan 20.

PMID:
24445092
10.

Minimally-invasive treatment of early stage breast cancer: a feasibility study using radiofrequency ablation under local anesthesia.

Schässburger KU, Löfgren L, Lagerstedt U, Leifland K, Thorneman K, Sandstedt B, Auer G, Wiksell H.

Breast. 2014 Apr;23(2):152-8. doi: 10.1016/j.breast.2013.12.007. Epub 2014 Jan 1.

11.

Correlation of contrast-enhanced ultrasound kinetics with prognostic factors in invasive breast cancer.

Szabó BK, Saracco A, Tánczos E, Aspelin P, Leifland K, Wilczek B, Axelsson R.

Eur Radiol. 2013 Dec;23(12):3228-36. doi: 10.1007/s00330-013-2960-5. Epub 2013 Jul 3.

PMID:
23821023
12.

Mass detection in reconstructed digital breast tomosynthesis volumes with a computer-aided detection system trained on 2D mammograms.

van Schie G, Wallis MG, Leifland K, Danielsson M, Karssemeijer N.

Med Phys. 2013 Apr;40(4):041902. doi: 10.1118/1.4791643.

PMID:
23556896
13.
14.

Differentiation between benign and malignant breast tumors using kinetic features of real-time harmonic contrast-enhanced ultrasound.

Saracco A, Szabó BK, Aspelin P, Leifland K, Wilczek B, Celebioglu F, Axelsson R.

Acta Radiol. 2012 May 1;53(4):382-8. doi: 10.1258/ar.2012.110562. Epub 2012 Mar 20.

PMID:
22434928
15.

Two-view and single-view tomosynthesis versus full-field digital mammography: high-resolution X-ray imaging observer study.

Wallis MG, Moa E, Zanca F, Leifland K, Danielsson M.

Radiology. 2012 Mar;262(3):788-96. doi: 10.1148/radiol.11103514. Epub 2012 Jan 24.

PMID:
22274840
16.

Correlating locations in ipsilateral breast tomosynthesis views using an analytical hemispherical compression model.

van Schie G, Tanner C, Snoeren P, Samulski M, Leifland K, Wallis MG, Karssemeijer N.

Phys Med Biol. 2011 Aug 7;56(15):4715-30. doi: 10.1088/0031-9155/56/15/006. Epub 2011 Jul 8.

PMID:
21737868
17.

Effects of percutaneous estradiol-oral progesterone versus oral conjugated equine estrogens-medroxyprogesterone acetate on breast cell proliferation and bcl-2 protein in healthy women.

Murkes D, Conner P, Leifland K, Tani E, Beliard A, Lundström E, Söderqvist G.

Fertil Steril. 2011 Mar 1;95(3):1188-91. doi: 10.1016/j.fertnstert.2010.09.062. Epub 2010 Nov 10.

18.

Prevention of tumour cell dissemination in diagnostic needle procedures.

Wiksell H, Schässburger KU, Janicijevic M, Leifland K, Löfgren L, Rotstein S, Sandberg PO, Wadström C, Auer G.

Br J Cancer. 2010 Nov 23;103(11):1706-9. doi: 10.1038/sj.bjc.6605964. Epub 2010 Nov 2.

19.

Feasibility study on the treatment of small breast carcinoma using percutaneous US-guided preferential radiofrequency ablation (PRFA).

Wiksell H, Löfgren L, Schässburger KU, Grundström H, Janicijevic M, Lagerstedt U, Leifland K, Nybom R, Rotstein S, Saracco A, Schultz I, Thorneman K, Wadström C, Westman L, Wigzell H, Wilczek B, Auer G, Sandstedt B.

Breast. 2010 Jun;19(3):219-25. doi: 10.1016/j.breast.2010.01.016. Epub 2010 Feb 18.

20.

Bolus compared with continuous infusion of microbubble contrast agent using real-time contrast harmonic imaging ultrasound in breast tumors.

Saracco A, Aspelin P, Leifland K, Themudo R, Wilczek B, Axelsson R.

Acta Radiol. 2009 Oct;50(8):854-9. doi: 10.1080/02841850903085576.

PMID:
19634024
21.

Stereotactic core needle biopsy in non-palpable breast lesions. What number is needed?

Leifland K, Lundquist H, Lagerstedt U, Svane G.

Acta Radiol. 2004 Apr;45(2):142-7.

PMID:
15191096
22.
23.
24.

Pre-operative simultaneous stereotactic core biopsy and fine-needle aspiration biopsy in the diagnosis of invasive lobular breast carcinoma.

Leifland K, Lundquist H, Måre K, Erhardt K, Fernstad R.

Acta Radiol. 2000 Jan;41(1):57-60.

PMID:
10665872
25.

The general mammography screening program in Stockholm. Organisation and first-round results.

Lidbrink EK, Törnberg SA, Azavedo EM, Frisell JO, Hjalmar ML, Leifland KS, Sahlstedt TB, Skoog L.

Acta Oncol. 1994;33(4):353-8.

PMID:
8018365

Supplemental Content

Loading ...
Support Center